August 09,2007
Grassley Seeks FDA Briefing on Steps to Ensure Safety of Foreign-made Medicine
WASHINGTON – Sen. Chuck Grassley, ranking member of the Committee on Finance, is asking the Food and Drug Administration for an explanation of its steps to ensure the safety of foreign-made medicine. In a letter to the agency commissioner, Grassley said he is disturbed by reports of the inadequacy of FDA inspections of foreign pharmaceutical manufacturing facilities, especially given the growing predominance of overseas manufacturing of such products.
The text of Grassley’s letter follows here.
###
Next Article Previous Article
Recent News
- Wyden Statement on New Biden-Harris Administration Affordable Housing Initiative
- Wyden Hearing Statement on Tax Court Nominations
- Wyden, Crapo Lead Introduction of Bipartisan Bill to Improve Unemployment Insurance
- Wyden Renews Call for PBM Reforms Needed to Lower Drug Prices and Increase Access Following New FTC Report
- Wyden and Whitehouse Ask Attorney General to Appoint Special Counsel to Investigate Potential Ethics and Tax Law Violations by Justice Clarence Thomas and His Benefactors